- Recent advances in the management of pediatric acute lymphoblastic leukemia2016 | Second Faculty of Medicine
- Proteomic analysis of soluble proteins important in pediatric acute lymphoblastic leukemia2010 | Second Faculty of Medicine
- AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia2018 | Second Faculty of Medicine
- Pharmacogenetics of the central nervous system-toxicity and relapse affecting the cns in pediatric acute lymphoblastic leukemia2021 | Second Faculty of Medicine
- Plethysmographic and Biochemical Markers in the Diagnosis of Endothelial Dysfunction in Pediatric Acute Lymphoblastic Leukemia Survivors - New Applications2018 | Faculty of Medicine in Pilsen
- Frequency and prognostic impact of ZEB2 H1038 and 1072 mutations in childhood B-other acute lymphoblastic leukemia2021 | Second Faculty of Medicine
- Cytokines, growth, and environment factors in bone marrow plasma of acute lymphoblastic leukemia pediatric patients2014 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch2021 | Second Faculty of Medicine
- Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria2010 | Second Faculty of Medicine
- Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria2010 | First Faculty of Medicine
- Remission, treatment failure, and relapse in pediatric ALL: An international consensus of the Ponte-di-Legno Consortium2022 | Second Faculty of Medicine
- Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL2019 | Second Faculty of Medicine
- Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Acute Lymphoblastic Leukemia Intercontinental-Berlin-Frankfurt-Münster 2009 Trial2023 | Second Faculty of Medicine
- The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG2021 | Second Faculty of Medicine